Dark Forest Capital Management LP Nevro Corp Transaction History

Dark Forest Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$18.22 - $25.85 $311,489 - $441,931	17,096 New	17,096 $328,000
Q1 2023 May 12, 2023	BUY	$30.17 - $41.11 $66,947 - $91,223	2,219 New	2,219 $80,000
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $2,398 - $3,128	59 New	59 $3,000
Q2 2022 Aug 15, 2022	SELL	$40.85 - $77.67 $63,154 - $120,077	-1,546 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$59.95 - $92.06 $57,911 - $88,929	966 Added 166.55%	1,546 $111,000
Q4 2021 Feb 11, 2022	BUY	$81.07 - $121.29 $47,020 - $70,348	580 New	580 $47,000
Q3 2021 Nov 12, 2021	SELL	$101.99 - $166.36 $1,019 - $1,663	-10 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$141.6 - $179.06 $1,416 - $1,790	10 New	10 $2,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.